US2021147778A1PendingUtilityA1
Biomimetic device
Est. expiryJun 12, 2034(~7.9 yrs left)· nominal 20-yr term from priority
C12M 25/02C12M 23/16C12M 23/20
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are apparatus comprising: a first layer comprising a first microfluidic channel; a second layer comprising a second microfluidic channel; and a membrane for culturing cells; along with methods of making and using same.
Claims
exact text as granted — not AI-modified1 - 35 . (canceled)
36 . An apparatus comprising:
a first layer formed of an elastomeric material, the first layer comprising a first microfluidic channel having a first length and a first width; a second layer formed of an elastomeric material, the second layer comprising a second microfluidic channel having a second length and a second width; and a membrane for culturing cells having a first major surface and a second major surface.
37 . The apparatus according to claim 36 , wherein the membrane is configured to have a layer of first cells disposed on a major surface of the membrane.
38 . The apparatus according to claim 36 , wherein at least a portion of the membrane for culturing cells is semi-permeable and is positioned between the first layer and the second layer.
39 . The apparatus according to claim 36 , wherein the first layer and second layer comprise the same material.
40 . The apparatus according to claim 36 , wherein the membrane for culturing cells comprises a material selected from a polycarbonate, a polyester, polyethylene terephthalate, a mixed cellulose ester, PDMS and a combination of two or more thereof.
41 . The apparatus according to claim 36 , wherein the membrane for culturing cells is in fluid communication with one or both of the first and second layers.
42 . The apparatus according to claim 36 , wherein the membrane for culturing cells is adapted to culture a plurality of cell lines.
43 . The apparatus according to claim 36 , wherein the first major surface of the membrane is adapted to culture a first cell line.
44 . The apparatus according to claim 42 , wherein the second major surface of the membrane is adapted to culture a second cell line.
45 . The apparatus according to claim 43 , wherein the first major surface comprises a first layer of cells comprising a first cell line.
46 . The apparatus according to claim 44 , wherein the second major surface comprises a second layer of cells comprising a second cell line.
47 . The apparatus according to claim 45 , wherein the first cell line comprises endothelial cells, smooth muscle cells, tumor cells, stem cells, alveolar cells, epithelial cells, nerve cells, hepatic cells or a combination thereof.
48 . The apparatus according to claim 46 , wherein the second cell line comprises endothelial cells, smooth muscle cells, tumor cells, stem cells, alveolar cells, epithelial cells, nerve cells, hepatic cells or a combination thereof.
49 . The apparatus according to claim 47 , wherein the first layer of cells comprises endothelial cells or tumor cells.
50 . The apparatus according to claim 49 , wherein the second layer of cells comprises smooth muscle cells or tumor cells.
51 . The apparatus according to claim 46 , wherein the first major surface of the membrane faces the first microfluidic channel; and wherein the second major surface of the membrane faces the second microfluidic channel.
52 . The apparatus according to claim 36 , further comprising a treatment agent provided in one of the first and second microfluidic channels.
53 . The apparatus according to claim 36 , for use in combination with a 96-well plate.
54 . The apparatus according to claim 36 , wherein the elastomeric material is selected from an organosilicon, silicon, glass, polystyrene, polyvinyl chloride, polymethyl methacrylate, cyclic olefin copolymer, polycarbonate and a combination of two or more thereof.Join the waitlist — get patent alerts
Track US2021147778A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.